Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
F-Star Therapeutics Inc
(NQ:
FSTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about F-Star Therapeutics Inc
invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
March 08, 2023
From
invoX Pharma
Via
Business Wire
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
March 07, 2023
Parties expect the merger to be completed promptly following the successful completion of the ongoing Tender Offer
From
F-star Therapeutics, Inc.
Via
GlobeNewswire
invoX Pharma and F-star Therapeutics issue Joint Statement
January 26, 2023
From
F-star Therapeutics, Inc.
Via
GlobeNewswire
F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress
December 06, 2022
FS222 demonstrated early antitumor activity with one complete response and six disease stabilizations in patients with advanced solid tumors
From
F-star Therapeutics, Inc.
Via
GlobeNewswire
F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research
November 07, 2022
From
F-star Therapeutics, Inc.
Via
GlobeNewswire
F-STAR THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of F-star Therapeutics, Inc. - FSTX
July 15, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
FSTX STOCK ALERT: Halper Sadeh LLP Is Investigating Whether the Sale of F-star Therapeutics, Inc. Is Fair to Shareholders
July 14, 2022
From
Halper Sadeh LLP
Via
Business Wire
F-STAR THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of F-star Therapeutics, Inc. - FSTX
June 23, 2022
From
Kahn Swick & Foti, LLC
Via
Business Wire
FSTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of F-star Therapeutics, Inc. Is Fair to Shareholders
June 23, 2022
From
Halper Sadeh LLP
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.